A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma.

Pratt, Guy and Yap, Christina and Oldreive, Ceri and Slade, Daniel and Bishop, Rebecca and Griffiths, Mike and Dyer, Martin J S and Fegan, Chris and Oscier, David and Pettitt, Andrew and Matutes, Estella and Devereux, Stephen and Allsup, David and Bloor, Adrian and Hillmen, Peter and Follows, George and Rule, Simon and Moss, Paul and Stankovic, Tatjana (2018) A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. British journal of haematology, 182 (3). pp. 429-433. ISSN 1365-2141. This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs

Full text not available from this repository.
Official URL: https://onlinelibrary.wiley.com/doi/full/10.1111/b...
Item Type: Article
Additional Information: This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs
Subjects: QZ Pathology. Oncology
WH Haemic and lymphatic systems. Haematology
Divisions: Planned IP Care > Oncology and Clinical Haematology
Related URLs:
Depositing User: Beth Connors
Date Deposited: 21 Jun 2019 11:23
Last Modified: 21 Jun 2019 11:23
URI: http://www.repository.heartofengland.nhs.uk/id/eprint/2164

Actions (login required)

View Item View Item